Cargando…
Closure Device-Related Thrombosis After Anticoagulation With Dabigatran in Patients Undergoing Percutaneous Left Atrial Appendage Closure: Case Reports and Literature Review
Percutaneous left atrial appendage closure (LAAC) is an effective and safe operation strategy for stroke prevention in patients who are diagnosed with atrial fibrillation (AF) but cannot tolerate long term anticoagulation medication. We presented four rare cases of thrombosis formation on the occlud...
Autores principales: | Li, Xiaoye, Jin, Qinchun, Zhang, Xiaochun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506050/ https://www.ncbi.nlm.nih.gov/pubmed/33013399 http://dx.doi.org/10.3389/fphar.2020.563920 |
Ejemplares similares
-
Clinical Efficacy and Safety Comparison of Rivaroxaban and Dabigatran for Nonvalvular Atrial Fibrillation Patients Undergoing Percutaneous Left Atrial Appendage Closure Operation
por: Li, Xiaoye, et al.
Publicado: (2021) -
The Impact of Dabigatran and Rivaroxaban on Variation of Platelet Activation Biomarkers and DRT Following Percutaneous Left Atrial Appendage Closure
por: Li, Xiaoye, et al.
Publicado: (2021) -
Percutaneous closure of “hidden” left atrial appendage with Ultraseal device
por: Moreno-Samos, Jose Carlos, et al.
Publicado: (2019) -
Left Atrial Appendage Closure Devices
por: Romero, Jorge, et al.
Publicado: (2014) -
Pericardial Effusion During the Perioperative Period for Left Atrial Appendage Closure
por: Yang, Lifan, et al.
Publicado: (2021)